SOURCE: Progressive Care Inc

Progressive Care Inc

January 05, 2016 08:00 ET

Progressive Care Names Shital Mars Chief Executive Officer

MIAMI, FL--(Marketwired - January 05, 2016) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME") and the supply of prescription medications to long term care facilities, announces Shital Mars as new CEO.

Ms. Mars who currently serves as the Chief Operating Officer will succeed Alan Jay Weisberg as of January 4, 2016. Mr. Weisberg will remain the Chief Financial Officer of the Company as well as Chairman of the Board of Directors.

"We are grateful to have worked with Ms. Mars for the last 3 years as our Chief Operating Officer. After delivering a strong track record of dedicated service, executed growth initiatives, and exhibition of strong leadership, we believe that now is the time to transition to Ms. Mars as the CEO of the Company," Mr. Weisberg stated.

Ms. Mars attended Florida International University and has a BS in Business Administration and Accounting. Prior to joining Progressive Care, she was the COO of a boutique brokerage firm and currently maintains several securities licenses including the Series 7, Series 24, and Series 27. She and her husband, Bruce Mars, recently welcomed their first child, a son, in September 2015.

"I am excited and honored for the opportunity to lead this talented team," Ms. Mars stated. "I believe that over the past three years we have fundamentally changed the company to one that goes well beyond filling prescriptions. Progressive Care through the PharmCo brand is a leader in the health services industry paving the path of best practices and innovating more efficient ways to manage patient care and well-being. Now is the time to achieve the Company's true potential by aggressively expanding the brand, developing new products and services, and delivering long term profitability. I am confident that this Company's best days are in front of it and could not be happier to be the leader that drives it forward."

About Progressive Care

Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment and the supply of prescription medications to long term care facilities.

Cautionary Statement Regarding Forward Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target", "intend" and "expect" and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.